Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome
Baseline serum syndecan-1 is associated with unfavorable kidney outcomes and cardiovascular risk factors in INS.
Authors
- Richard J. Johnson (ORCID: https://orcid.org/0000-0003-3312-8193)
- William E. Smoyer (ORCID: https://orcid.org/0000-0003-1982-9938)
- Colin Bauer
- Julie Dougherty (ORCID: https://orcid.org/0000-0001-5778-1512)
- Gabriel Cara‐Fuentes (ORCID: https://orcid.org/0000-0002-4164-3251)
- Tarak Srivastava (ORCID: https://orcid.org/0000-0002-8654-0627)
- Jonathan P. Troost (ORCID: https://orcid.org/0000-0002-1183-8330)
- Md Imtiazul Islam (ORCID: https://orcid.org/0000-0002-0020-6733)
- Arshia Anand
- Christine B. Sethna
- Audrey Rose Fetsko
Institutions
- Children's Mercy Hospital (US)
- University of Michigan (US)
- Cohen Children's Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.055
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Nephcure Foundation
- Alport Syndrome Foundation
- Rare Diseases Clinical Research Network
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences